MediLink Therapeutics, BioNTech expand partnership with new $1.8bn agreement
MediLink Therapeutics (Suzhou) Co., Ltd., a prominent clinical-stage biotech company, has entered into a significant new strategic collaboration with BioNTech SE, a leader in next-generation ... Read More
Suven Pharmaceuticals and Cohance Lifesciences announce merger
In a significant development in the pharmaceutical industry, Suven Pharmaceuticals Limited (Suven) and Cohance Lifesciences Limited (Cohance) have announced a proposed scheme of amalgamation, marking ... Read More